Federal Register / Vol. 84, No. 150 / Monday, August 5, 2019 / Notices 38031 

susceptible subpopulations, 

alternatives, and regulatory options for 

chemicals being evaluated or regulated, 

EPA would be able to more efficiently 

and effectively carry out its mandate 

under TSCA to protect human health 

and the environment from unreasonable 

risks. 

EPA would not collect information of 

a sensitive or private nature. However, 

respondents may claim information 

provided in an interview or focus group 

as CBI under TSCA section 14. Please 

refer to TSCA section 14(b) to 

understand what information is not 

protected from disclosure. For example, 

TSCA section 14(a) does not prohibit 

the disclosure of information from 

health and safety studies that are 

submitted under TSCA. Information on 

the requirements for asserting CBI 

claims under TSCA can be found at 

https://www.epa.gov/tsca-cbi/makingcbi-claims-tsca-submissions. EPA would 

disclose information that is covered by 

a claim of confidentiality only to the 

extent permitted by, and in accordance 

with, the procedures of TSCA section 

14, which provides advance notice and 

an opportunity to object prior to public 

disclosure. 

Burden statement: The annual public 

reporting and recordkeeping burden for 

this collection of information is 

estimated to average 2 hours per 

response. Burden is defined in 5 CFR 

1320.3(b). The ICR, which is available in 

the docket along with other related 

materials, provides a detailed 

explanation of the collection activities 

and the burden estimate that is only 

briefly summarized here: 

Respondents/Affected entities: 

Potential respondents include chemical 

manufacturers, chemical users, 

processors, distributors, manufacturers 

(including importers), recyclers, 

chemical waste handlers, consumers, 

employees, state regulators, nongovernmental organizations, and 

industry experts about the chemical 

being evaluated or considered for risk 

management under TSCA. As such, 

there are no typical respondent NAICS 

codes and the respondents will vary 

depending on the conditions of use of 

each chemical under consideration. 

Estimated total number of potential 

respondents: 600. 

Frequency of response: On occasion, 

as necessary to support risk evaluation 

and management of existing chemicals. 

Estimated total average number of 

responses for each respondent: One. 

Estimated total annual burden hours: 

400 hours. 

Estimated total annual costs: $31,008. 

This includes an estimated burden cost 

of $31,008 and an estimated cost of $0 

for capital investment or maintenance 

and operational costs. 

V. What is the next step in the process 

for these ICRs? 

EPA will consider the comments 

received and amend the individual ICRs 

as appropriate. The final ICR packages 

will then be submitted to OMB for 

review and approval pursuant to 5 CFR 

1320.10. EPA will issue another Federal 

Register document pursuant to 5 CFR 

1320.5(a)(1)(iv) to announce the 

submission of these ICRs to OMB and 

the opportunity for the public to submit 

additional comments for OMB 

consideration. If you have any questions 

about any of these ICRs or the approval 

process in general, please contact the 

person listed under FOR FURTHER

INFORMATION CONTACT. 

Authority: 44 U.S.C. 3501 et seq. 

Dated: July 18, 2019. 

Alexandra Dapolito Dunn, 

Assistant Administrator, Office of Chemical 

Safety and Pollution Prevention. 

[FR Doc. 2019–16616 Filed 8–2–19; 8:45 am] 

BILLING CODE 6560–50–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Final Effect of Designation of a Class 

of Employees for Addition to the 

Special Exposure Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention, Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HHS gives notice concerning 

the final effect of the HHS decision to 

designate a class of employees from the 

Idaho National Laboratory in Scoville, 

Idaho, as an addition to the Special 

Exposure Cohort (SEC) under the Energy 

Employees Occupational Illness 

Compensation Program Act of 2000. 

FOR FURTHER INFORMATION CONTACT

Division of Compensation Analysis and 

Support, NIOSH, 1090 Tusculum 

Avenue, MS C–46, Cincinnati, OH 

45226–1938, Telephone 513–533–6800. 

Information requests can also be 

submitted by email to DCAS@CDC.GOV. 

: The 

SUPPLEMENTARY INFORMATION On June 

21, 2019, as provided for under 42 

U.S.C. 7384l(14)(C), the Secretary of 

HHS designated the following class of 

employees as an addition to the SEC: 

: 

All employees of the Department of 

Energy, its predecessor agencies, and their 

contractors and subcontractors who worked 

at the Idaho National Laboratory (INL) in 

Scoville, Idaho, and who were monitored for 

external radiation at the Idaho Chemical 

Processing Plant (CPP) (e.g., at least one film 

badge or TLD dosimeter from CPP) between 

January 1, 1963, and February 28, 1970, for 

a number of work days aggregating at least 

250 work days, occurring either solely under 

this employment, or in combination with 

work days within the parameters established 

for one or more other classes of employees 

in the Special Exposure Cohort. 

This designation became effective on 

July 21, 2019. Therefore, beginning on 

July 21, 2019, members of this class of 

employees, defined as reported in this 

notice, became members of the SEC. 

Authority: 42 U.S.C. 7384q(b). 42 U.S.C. 

7384l(14)(C). 

John J. Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2019–16602 Filed 8–2–19; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Council for the Elimination of 

Tuberculosis (ACET) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

of the Advisory Council for the 

Elimination of Tuberculosis Meeting 

(ACET). This meeting is open to the 

public, limited only by 60 room seating 

and 100 ports for audio phone lines. 

Time will be available for public 

comment. The public is welcome to 

submit written comments in advance of 

the meeting. Comments should be 

submitted in writing by email to the 

contact person listed below. The 

deadline for receipt is Monday, August 

19, 2019. Persons who desire to make an 

oral statement, may request it at the 

time of the public comment period on 

August 20, 2019 at 3:20 p.m. EDT. 

DATES: The meeting will be held on 

August 20, 2019, 10:00 a.m. to 3:30 

p.m., EDT. 

ADDRESSES: 8 Corporate Blvd., Building 

8, Conference Rooms 1A and 1B, 

Atlanta, Georgia 30329 and Web 

conference: 1–877–927–1433 and 

participant passcode: 12016435 and 


jspears on DSK3GMQ082PROD with NOTICES